Financials
Income statement
Fiscal date | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|
Total reported revenue | 48.1B | 64.2B | 53.0B | 43.1B |
Cost of revenue | 29.1B | 36.2B | 31.9B | 26.1B |
Gross profit | 19.0B | 28.0B | 21.1B | 17.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | — | — | — | — |
Operating income | 1.6B | 9.3B | 5.5B | 2.5B |
Non operating interest income | ||||
Income | 106M | 94M | 87M | 143M |
Expense | 83M | 120M | 262M | 226M |
Other income expense | — | — | — | — |
Pretax income | 1.1B | 6.4B | 5.0B | 2.3B |
Tax provision | 360M | 2.9B | 1.2B | 521M |
Net income | 772M | 3.4B | 3.8B | 1.8B |
Basic EPS | — | — | — | 19.7 |
Diluted EPS | — | — | — | 19.7 |
Basic average shares | — | — | — | 91.6M |
Diluted average shares | — | — | — | 91.6M |
EBITDA | 1.3B | 9.3B | 5.3B | 2.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |